Apicidin suppresses transcription of 17β-hydroxysteroid dehydrogenase type 1 in endometrial adenocarcinoma cells
- PMID: 21086175
- DOI: 10.1007/s11033-010-0441-3
Apicidin suppresses transcription of 17β-hydroxysteroid dehydrogenase type 1 in endometrial adenocarcinoma cells
Abstract
It has recently been reported that endometrial cancer cells are able to convert estron (E1) to 17β estradiol (E2). We observed the presence of 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) transcript and protein in receptor positive ER(+) and negative ER(-) Ishikawa endometrial adenocarcinoma (ISH) cells. ER(+) ISH, but not ER(-)02 ISH, cells were significantly susceptible to apicidin induced death, and we further used ER(-)ISH cells to study the effect of apicidin on cellular levels of HSD17B1 transcript and protein. We showed that apicidin significantly lowered HSD17B1 transcript and protein levels in ISH cells. There was no significant effect on HSD17B1 transcript stability. However, chromatin immunoprecipitation analysis revealed that apicidin significantly decreased occupation of the first exon of the HSD17B1 gene by Polymerase II. Since intratumoral E1 to E2 conversion is a significant contributor to the progression of estrogen dependent cancers, and HDAC inhibitors are being tested in anticancer clinical trials, our observations may have clinical value.
Similar articles
-
Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.Mol Cell Endocrinol. 2006 Mar 27;248(1-2):114-7. doi: 10.1016/j.mce.2005.10.013. Epub 2005 Dec 6. Mol Cell Endocrinol. 2006. PMID: 16337331
-
Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.Mol Cell Endocrinol. 2017 Jan 5;439:175-186. doi: 10.1016/j.mce.2016.08.026. Epub 2016 Aug 18. Mol Cell Endocrinol. 2017. PMID: 27544780
-
Steroid sulphotransferase and 17beta-hydroxysteroid dehydrogenase activities in Ishikawa human endometrial adenocarcinoma cells.J Steroid Biochem Mol Biol. 1997 Apr;61(1-2):27-34. doi: 10.1016/s0960-0760(97)00010-1. J Steroid Biochem Mol Biol. 1997. PMID: 9328207
-
17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.Mol Cell Endocrinol. 2006 Mar 27;248(1-2):136-40. doi: 10.1016/j.mce.2005.11.038. Epub 2006 Jan 6. Mol Cell Endocrinol. 2006. PMID: 16406263 Review.
-
Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Oncotarget. 2017 May 2;8(18):30552-30562. doi: 10.18632/oncotarget.15547. Oncotarget. 2017. PMID: 28430630 Free PMC article. Review.
Cited by
-
Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma.Dis Markers. 2021 Nov 12;2021:7850688. doi: 10.1155/2021/7850688. eCollection 2021. Dis Markers. 2021. PMID: 34804263 Free PMC article. Review.
-
Epigenetic therapy for breast cancer.Int J Mol Sci. 2011;12(7):4465-87. doi: 10.3390/ijms12074465. Epub 2011 Jul 11. Int J Mol Sci. 2011. PMID: 21845090 Free PMC article. Review.
-
HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression.Oncol Lett. 2018 Nov;16(5):6552-6560. doi: 10.3892/ol.2018.9468. Epub 2018 Sep 20. Oncol Lett. 2018. PMID: 30405794 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources